More

    ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkins



    [
    ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkins
    [og_img]
    https://www.investing.com/news/press-releases/zyversa-therapeutics-announces-published-data-showing-inflammasome-asc-inhibitor-ic-100-decreases-microglial-inflammasome-activation-and-alphasynuclein-that-contribute-to-neurodegeneration-in-parkins-93CH-4010604


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    spot_imgspot_img